Evaluation of the Effect of tDCS on Cannabis Craving
Paraules clau
Resum
Dates
| Darrera verificació: | 04/30/2020 |
| Primer enviat: | 04/26/2020 |
| Inscripció estimada enviada: | 05/12/2020 |
| Publicat per primera vegada: | 05/14/2020 |
| Última actualització enviada: | 05/12/2020 |
| Publicació de l'última actualització: | 05/14/2020 |
| Data d'inici de l'estudi real: | 09/16/2018 |
| Data estimada de finalització primària: | 07/16/2021 |
| Data estimada de finalització de l’estudi: | 12/16/2021 |
Condició o malaltia
Intervenció / tractament
Other: Neuromodulation by tDCS
Fase
Grups de braços
| Braç | Intervenció / tractament |
|---|---|
| Experimental: tDCS active arm | |
| Placebo Comparator: tDCS placebo |
Criteris d'elegibilitat
| Edats elegibles per estudiar | 18 Years Per a 18 Years |
| Sexes elegibles per estudiar | All |
| Accepta voluntaris saludables | Sí |
| Criteris | Inclusion Criteria: 1. Men or women between 18 and 65 years of age 2. Right-Handers 3. Diagnosis: Cannabis Use Disorder (according to DSM 5 criteria) 4. Patient with no other drug or psychotherapeutic treatment for cannabis addiction ("naive" patients) 5. Reported use of cannabis more than three times a week in the past three years 6. Signing consent to participate in research Exclusion Criteria: 1. Pregnancy or lack of effective contraception 2. Patients with severe somatic disease 3. Other addictions of "moderate" to "severe" intensity according to DSM 5 criteria (excluding tobacco and coffee) 4. Patients undergoing antidepressant or neuroleptic or thyroid-regulating therapy. 5. Contraindications to tDCS (presence of an intracranial metal body, intracranial hypertension) 6. Topic that has already been stimulated by tDCS 7. Patients under reinforced guardianship or curatorship |
Resultat
Mesures de resultats primaris
1. Evaluating the change from craving to cannabis. by an analog visual scale .Scores (0 to 10) [3 months]
Mesures de resultats secundaris
1. The change to cannabis craving assessed by the Baseline Marijuana Craving Test at the end of treatment [3 month]
2. The change in cannabis craving during an incentive to use task evaluated by analog visual scale scores (0 to 10) [3 months]
3. Montgomery-Åsberg depression rating scale) Scores (0 to 60) [3 months]
4. evaluation of the change in the number of joints consumed per day [3 months]
5. evaluation of the change in the number of cigarettes consumed per day [3 months]
6. assessment of the change in attention and inhibition skills as assessed by the Stroop test before and after a neurofeedback test [3 months]
7. the Gambling Task's assessment of decreased risk-taking [3 months]
8. Young Mania Rating Scale Scores (0 to 60) [3 months]
9. Beck Depression Inventory Scores (0 to 39) [3 months]
10. Clinical Global Impression Severity of disease (0 to 7) [3 months]
